📌 Key Takeaways
- Topic: Silica OEM: How Private-Label and Custom Silica Manufacturing Works
- Keywords: silica tapped density
- Published: 2026-11-20 08:14:18
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica as an Anti-Caking Agent: Mechanism, Dosage and Applications
- Is Silica in Toothpaste Safe? Abrasiveness, Enamel Effects and Safety
- 6.2.3. Oral Drug Administration
- Silica Manufacturer in India: Key Producers, Product Ranges and Export Capabilities
- How to Request a Silica Quote: Information Suppliers Need for Accurate Pricing
- 48. Szegedi Á., Trendafilova I., Mihály J., Lázár K., Németh P., Momekov G., Momekova D., Marinov L., Nikolova I., Popova M. New insight on prednisolone polymorphs in mesoporous silica/maghemite nanocomposites. J. Drug Deliv. Sci. Technol. 2020;60:102092. doi: 10.1016/j.jddst.2020.102092. [ DOI ] [ Google Scholar ]
- Thermal Conductive Filler: Silica vs Alumina vs Boron Nitride Compared
- 13. Lamson N.G., Berger A., Fein K.C., Whitehead K.A. Anionic nanoparticles enable the oral delivery of proteins by improving intestinal permeability. Nat. Biomed. Eng. 2020;4:84-96. doi: 10.1038/s41551-019-0465-5. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]
Quartz Crucible Sand: Purity Requirements and Role in Solar and Semiconductor Crucibles
What is silica (SiO₂)?
One of the biggest challenges of tableting greatly potent APIs (antibiotics, hormones, cytostatic molecules) is to attain content uniformity [ 95, 96 ]. Since these molecules are used in small doses, it is demanding to attain a homogeneous powder mixture during mixing and to make sure this homogeneity until the end of tableting. Also, it is a hurdle to develop a reproducible method that ensures content uniformity for each production batch, since the specified dose must be made sure between batches, not just within one batch [ 95, 96 ]. A reliable alternative method is to use mesoporous silica as a carrier system rather than simple powder mixing, thus preventing the segregation and aggregation of the low-dose API during mixing and compression. In this case, the preloaded mesoporous carrier and the necessary excipients are mixed, and then the powder mixture can be compressed directly or after granulation. The drug loading can be controlled by the concentration of the drug solution used to fill the carrier systems, which affects the amount of the drug content in the concluding medicine [ 95, 96 ]. Based on this, nearly unlimitedly low doses can be formulated into tablets, even in a concentration of 0.01%, just by properly preparing the solution [ 96 ]. The technique is well-controllable and dependable, since each tablet has the same drug content and the desired content uniformity. Furthermore, the method can be used in both batch-based and continuous production [ 96 ]. This may be a promising finding because there is evidence that it is challenging to move from batch-based to continuous manufacturing while maintaining the desired drug content and content uniformity [ 94 ]. But it should be noted that in this study, no nanocarrier system was used [ 94 ], so utilizing MSN formulations could make an enormous improvement in developing continuous tablet manufacturing [ 96 ]. A study shown that MSN carriers can also be used in orodispersible films to enhance the dissolution of poorly water-soluble drugs [ 100 ]. Based on in vitro drug release studies, more than 90% of prednisolone was released within 2 min when the loaded MSN was incorporated into the formulation. This means a much faster, immediate release in comparison with formulations containing the free form of the drug. In addition, precise dosing can be accomplished utilizing nanocarriers for personalized medication; furthermore, enabling the production of low-dose preparations without content uniformity problems [ 100 ].
What is the difference between fumed silica and precipitated silica?
how to disperse fumed silica Mesoporous silica nanocarriers (MSNs) have emerged as considerable candidates in the pharmaceutical industry for drug delivery systems, suitable for a wide range of drugs. Absorbing the active pharmaceutical ingredients (APIs) into the pores can be handy in several ways. The narrow pores may stabilize the APIs in an amorphous state, thereby boosting its aqueous solubility and supplying protection for the encapsulated drug against various takes into consideration the human body, such as enzymatic or chemical degradation, which boosts the bioavailability of the product. Beside the overview of their main traits, the present review focuses on the recent findings on MSNs form therapeutic and drug formulation perspective, such as functionalization possibilities, as the size and surface of the particles influence the interactions with the cell membrane; therefore, the epithelial permeability of and release rate from the carrier, and may offer even targeted delivery in an organ-, tissue- or cell-specific manner, improving the therapy, also steering clear of drug-related side impacts.
What drives silica raw material prices?
silica matting agent
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.